GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » E10

Xtant Medical Holdings (FRA:XMS) E10 : €-8.95 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xtant Medical Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.028. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-8.95 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 10.90% per year. During the past 5 years, the average E10 Growth Rate was 17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Xtant Medical Holdings was 21.20% per year. The lowest was 10.90% per year. And the median was 14.00% per year.

As of today (2024-06-10), Xtant Medical Holdings's current stock price is €0.61. Xtant Medical Holdings's E10 for the quarter that ended in Mar. 2024 was €-8.95. Xtant Medical Holdings's Shiller PE Ratio of today is .


Xtant Medical Holdings E10 Historical Data

The historical data trend for Xtant Medical Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings E10 Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.16 -12.62 -14.59 -13.42 -10.80

Xtant Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.46 -12.05 -11.95 -10.80 -8.95

Competitive Comparison of Xtant Medical Holdings's E10

For the Medical Devices subindustry, Xtant Medical Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Shiller PE Ratio falls into.



Xtant Medical Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xtant Medical Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.028/131.7762*131.7762
=-0.028

Current CPI (Mar. 2024) = 131.7762.

Xtant Medical Holdings Quarterly Data

per share eps CPI Adj_EPS
201406 -2.811 100.560 -3.684
201409 -1.609 100.428 -2.111
201412 -4.337 99.070 -5.769
201503 -6.252 99.621 -8.270
201506 -3.987 100.684 -5.218
201509 -6.224 100.392 -8.170
201512 9.718 99.792 12.833
201603 -5.025 100.470 -6.591
201606 -3.921 101.688 -5.081
201609 -4.243 101.861 -5.489
201612 -3.499 101.863 -4.527
201703 -3.590 102.862 -4.599
201706 -5.681 103.349 -7.244
201709 -4.681 104.136 -5.923
201712 -15.787 104.011 -20.001
201803 -0.564 105.290 -0.706
201806 -0.323 106.317 -0.400
201809 -0.204 106.507 -0.252
201812 -3.761 105.998 -4.676
201903 -0.184 107.251 -0.226
201906 -0.132 108.070 -0.161
201909 -0.126 108.329 -0.153
201912 -0.116 108.420 -0.141
202003 -0.172 108.902 -0.208
202006 -0.169 108.767 -0.205
202009 -0.085 109.815 -0.102
202012 -0.008 109.897 -0.010
202103 0.000 111.754 0.000
202106 -0.008 114.631 -0.009
202109 -0.017 115.734 -0.019
202112 -0.027 117.630 -0.030
202203 -0.027 121.301 -0.029
202206 -0.019 125.017 -0.020
202209 -0.030 125.227 -0.032
202212 -0.019 125.222 -0.020
202303 -0.019 127.348 -0.020
202306 -0.018 128.729 -0.018
202309 0.066 129.860 0.067
202312 -0.028 129.419 -0.029
202403 -0.028 131.776 -0.028

Add all the adjusted EPS together and divide 10 will get our e10.


Xtant Medical Holdings  (FRA:XMS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xtant Medical Holdings E10 Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (FRA:XMS) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines